Leukemia
Translation-related genes predict the course of chronic lymphocytic leukemia
Published in Gene Therapy Weekly, May 22nd, 2003
According to recent research from Germany, "B-cell chronic lymphocytic leukemia (B-CLL) is a heterogenous disease with a highly variable clinical course. Recent studies have shown that CD38 surface expression on the malignant cell clone may serve as a prognostic marker in that CD38(+) patients with B-CLL are characterized by advanced disease stage, lesser responsiveness to chemotherapy, and shorter survival than CD38(-) patients."
"To further investigate the molecular phenotype of these two clinical subgroups, we compared the gene expression profiles of CD38(+) (n = 25)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-05-22)
More Articles from Gene Therapy Weekly
- Liver Regeneration
Transduced liver stem cells could treat gene-based liver diseases - Respiratory Medicine
Steroids stop complications linked to gene therapy in donated lungs - Audiology
Immunosuppression reduces the adverse effects of adenovirus in the cochlea - Cardiology
Stress-protein Grp94 overexpression limits cardiomyocyte necrosis - DNA Research
Agents that alter the DNA landscape have several mechanistic differences - Antiangiogenesis
The EGR-1 corepressor NAB2 halts vascular endothelial growth factor induction - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
